Drug Guide
Chlorthalidone and Clonidine Hydrochloride
Classification
Therapeutic: Antihypertensive, Diuretic
Pharmacological: Chlorthalidone - Thiazide-like diuretic; Clonidine - Alpha-2 adrenergic agonist
FDA Approved Indications
- Hypertension
Mechanism of Action
Chlorthalidone inhibits sodium reabsorption in the distal tubules of the kidney, promoting diuresis. Clonidine stimulates alpha-2 adrenergic receptors in the brainstem, reducing sympathetic outflow, decreasing blood pressure.
Dosage and Administration
Adult: Dosage varies based on clinical response; typically, 12.5-25 mg daily for chlorthalidone and 0.1-0.3 mg twice daily for clonidine.
Pediatric: Use is not common; dosage should be individualized based on age and response.
Geriatric: Start at lower doses due to increased sensitivity and risk of side effects.
Renal Impairment: Adjust dose based on renal function; chlorthalidone can cause electrolyte imbalances.
Hepatic Impairment: Use with caution; monitor closely.
Pharmacokinetics
Absorption: Well absorbed orally.
Distribution: Widely distributed in body tissues.
Metabolism: Clonidine undergoes hepatic metabolism; chlorthalidone undergoes minimal metabolism.
Excretion: Renal excretion of unchanged drugs and metabolites.
Half Life: Chlorthalidone: ~40-50 hours; Clonidine: ~12-16 hours.
Contraindications
- Hypersensitivity to either drug
- Severe coronary artery disease (clonidine caution)
Precautions
- Orthostatic hypotension, renal impairment, hepatic impairment, pregnancy (clonidine caution), history of depression
Adverse Reactions - Common
- Dry mouth (common)
- Dizziness (common)
- Fatigue (common)
Adverse Reactions - Serious
- Bradycardia (rare)
- Electrolyte disturbances (hypokalemia, hyponatremia) (common)
- Rebound hypertension upon withdrawal (rare)
Drug-Drug Interactions
- Other antihypertensives, CNS depressants, MAO inhibitors
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor blood pressure, heart rate, electrolyte levels, renal function.
Diagnoses:
- Risk of hypotension
- Electrolyte imbalance
Implementation: Administer as prescribed, monitor patient response, educate patient about orthostatic hypotension and adherence.
Evaluation: Assess blood pressure and side effects regularly.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Change positions slowly to minimize dizziness.
- Do not discontinue abruptly to avoid rebound hypertension.
- Report signs of electrolyte imbalance or severe side effects.
Special Considerations
Black Box Warnings:
- Rebound hypertension if discontinued abruptly.
- Clonidine withdrawal symptoms: hypertension, tremors, headaches, nervousness.
Genetic Factors: N/A
Lab Test Interference: N/A
Overdose Management
Signs/Symptoms: Severe hypotension, bradycardia, sedation, respiratory depression.
Treatment: Supportive care, airway management, fluid replacement, atropine for bradycardia, and specific antidotes if available.
Storage and Handling
Storage: Store at room temperature, away from moisture and light.
Stability: Stable under typical storage conditions.